Please provide your email address to receive an email when new articles are posted on . Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke ...
GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback